title: New treatment options for psoriasis.
abstract: Psoriasis is a chronic genetic disease characterized by hyperproliferation and inflammation of the epidermis and dermis. Presently there is no cure for psoriasis, only treatments to alleviate the symptoms. Tazarotene (Tazorac) is a new vitamin A derivative and the first topical retinoid to demonstrate therapeutic success in treating plaque-type psoriasis. This article will introduce you and your patients to the safe and effective use of tazarotene.
authors.affiliation: University of California, San Francisco, USA.
authors.forename: P B
authors.initials: PB
authors.lastname: McClelland
mesh_terms: D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010353:Patient Education as Topic; D011355:Prodrugs / Q000008:administration & dosage / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy* / Q000451:nursing / Q000473:pathology; D012176:Retinoids
chemical_list: D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D009539:Nicotinic Acids; D011355:Prodrugs; C086827:tazarotene; D012176:Retinoids